White Plains, NY – According to filings with the U.S. Securities and Exchange Commission, Acurx Pharmaceuticals is raising $7,842,500.00 in new funding. Sources indicate as part of senior management Co-Founder and Managing Partner, David Luci played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Acurx Pharmaceuticals

Acurx Pharmaceuticals is a privately held clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

To learn more about Acurx Pharmaceuticals, visit http://www.acurxpharma.com/

Contact:
David Luci, Co-Founder and Managing Partner
914-949-3898
davidluci@acurxpharma.com
https://www.linkedin.com/in/david-luci-82626210/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved